Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
Context | Citation |
---|---|
Decreases Escherichia coli IAI1 - : ceftazidime |
👶
A systematic review and individual bacterial species level meta-analysis of in vitro studies on the efficacy of ceftazidime/avibactam combined with other antimicrobials against carbapenem-resistant Gram-negative bacteria. The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 80 Issue 2 Pages: 334-346 Pub: 2025 Feb 3 Epub: Authors Assefa GM , Roberts JA , Aslan AT , Mohammed SA , Sime FB , Html Article Publication |
Decreases Escherichia coli IAI1 - : ceftazidime |
👶
Pharmacokinetic/pharmacodynamic analysis of ceftazidime/avibactam and fosfomycin combinations in an in vitro hollow fiber infection model against multidrug-resistant Escherichia coli. Microbiology spectrum (Microbiol Spectr ) Vol: 12 Issue 1 Pages: e0331823 Pub: 2024 Jan 11 Epub: 2023 Dec 8 Authors Kroemer N , Amann LF , Farooq A , Pfaffendorf C , Martens M , Decousser J-W , Grégoire N , Nordmann P , Wicha SG , Html Article Publication |
Decreases Escherichia coli IAI1 - : ceftazidime |
👶
Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China. Chinese medical journal (Chin Med J (Engl) ) Vol: 126 Issue 12 Pages: 2207-14 Pub: 2013 Jun Epub: Authors Ye F , He LX , Cai BQ , Wen FQ , Chen BY , Hadiarto M , Chen RC , Yuan JP , Sun HL , |
0 π | π’ 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]